About this Journal Submit a Manuscript Table of Contents
Journal of Allergy
Volume 2010 (2010), Article ID 491928, 11 pages
http://dx.doi.org/10.1155/2010/491928
Review Article

Neural Pathways in Allergic Inflammation

1Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, Brazil
2Department of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, Brazil

Received 2 October 2010; Revised 30 November 2010; Accepted 8 December 2010

Academic Editor: Redwan Moqbel

Copyright © 2010 L. Mirotti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Ono, “Molecular genetics of allergic diseases,” Annual Review of Immunology, vol. 18, pp. 347–366, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. H. J. Gould and B. J. Sutton, “IgE in allergy and asthma today,” Nature Reviews Immunology, vol. 8, no. 3, pp. 205–217, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. W. E. Paul and J. Zhu, “How are TH2-type immune responses initiated and amplified?” Nature Reviews Immunology, vol. 10, no. 4, pp. 225–235, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. D. de Sousa Mucida, A. de Castro Keller, E. C. Fernvik, and M. Russo, “Unconventional strategies for the suppression of allergic asthma,” Current Drug Targets. Inflammation and Allergy, vol. 2, no. 2, pp. 187–195, 2003. View at Scopus
  5. L. Maddox and D. A. Schwartz, “The pathophysiology of asthma,” Annual Review of Medicine, vol. 53, pp. 477–498, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. R. Ader and N. Cohen, “Behaviorally conditioned immunosuppression,” Psychosomatic Medicine, vol. 37, no. 4, pp. 333–340, 1975. View at Scopus
  7. G. Pacheco-López, M. B. Niemi, W. Kou, M. Härting, J. Fandrey, and M. Schedlowski, “Neural substrates for behaviorally conditioned immunosuppression in the rat,” Journal of Neuroscience, vol. 25, no. 9, pp. 2330–2337, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. H. O. Besedovsky and A. del Rey, “Immune-neuro-endocrine interactions: facts and hypotheses,” Endocrine Reviews, vol. 17, no. 1, pp. 64–102, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Steinman, “Elaborate interactions between the immune and nervous systems,” Nature Immunology, vol. 5, no. 6, pp. 575–581, 2004. View at Publisher · View at Google Scholar · View at PubMed
  10. E. M. Smith and J. E. Blalock, “Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 12, pp. 7530–7534, 1981. View at Scopus
  11. J. E. Blalock, “The immune system as a sensory organ,” Journal of Immunology, vol. 132, no. 3, pp. 1067–1070, 1984. View at Scopus
  12. A. Kabiersch, A. del Rey, C. G. Honegger, and H. O. Besedovsky, “Interleukin-1 induces changes in norepinephrine metabolism in the rat brain,” Brain Behavior and Immunity, vol. 2, no. 3, pp. 267–274, 1988. View at Scopus
  13. H. O. Besedovsky and A. del Rey, “Central and peripheral cytokines mediate immune-brain connectivity,” Neurochemical Research. In press. View at Publisher · View at Google Scholar · View at PubMed
  14. L. M. Boulanger, G. S. Huh, and C. J. Shatz, “Neuronal plasticity and cellular immunity: shared molecular mechanisms,” Current Opinion in Neurobiology, vol. 11, no. 5, pp. 568–578, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. K. M. Scott, M. Von Korff, J. Ormel et al., “Mental disorders among adults with asthma: results from the World Mental Health Survey,” General Hospital Psychiatry, vol. 29, no. 2, pp. 123–133, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. H. Hashizume and M. Takigawa, “Anxiety in allergy and atopic dermatitis,” Current Opinion in Allergy and Clinical Immunology, vol. 6, no. 5, pp. 335–339, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. R. A. Nathan, “The burden of allergic rhinitis,” Allergy and Asthma Proceedings, vol. 28, no. 1, pp. 3–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. K. L. Lavoie, M. Joseph, and S. L. Bacona, “Psychological distress and occupational asthma,” Current Opinion in Allergy and Clinical Immunology, vol. 9, no. 2, pp. 103–109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. F. M. Atkins, “Food allergy and behavior: definitions, mechanisms and a review of the evidence,” Nutrition Reviews, vol. 44, no. s3, pp. 104–112, 1986. View at Scopus
  20. J. W. Crayton, “Adverse reactions to foods: relevance to psychiatric disorders,” Journal of Allergy and Clinical Immunology, vol. 78, no. 1, pp. 243–250, 1986. View at Scopus
  21. A. Gettis, “Food sensitivities and psychological disturbance: a review,” Nutrition and Health, vol. 6, no. 3, pp. 135–146, 1989. View at Scopus
  22. G. Addolorato, L. Marsigli, E. Capristo et al., “Anxiety and depression: a common feature of health care seeking patients with irritable bowel syndrome and food allergy,” Hepato-Gastroenterology, vol. 45, no. 23, pp. 1559–1564, 1998. View at Scopus
  23. A. C. Lyons and E. M. E. Forde, “Food allergy in young adults: perceptions and psychological effects,” Journal of Health Psychology, vol. 9, no. 4, pp. 497–504, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. N. J. Avery, R. M. King, S. Knight, and J. O. B. Hourihane, “Assessment of quality of life in children with peanut allergy,” Pediatric Allergy and Immunology, vol. 14, no. 5, pp. 378–382, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. D. J. Pearson, K. J. B. Rix, and S. J. Bentley, “Food allergy: how much in the mind? A clinical and psychiatric study of suspected food hypersensitivity,” The Lancet, vol. 1, no. 8336, pp. 1259–1261, 1983. View at Scopus
  26. R. Peveler, R. Mayou, E. Young, and M. Stoneham, “Psychiatric aspects of food-related physical symptoms: a community study,” Journal of Psychosomatic Research, vol. 41, no. 2, pp. 149–159, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. D. A. Lawrence and R. J. Wright, “Psychologic stress and asthma: neuropeptide involvement,” Environmental Health Perspectives, vol. 110, no. 5, pp. A230–A231, 2002, author reply A231. View at Scopus
  28. P. M. Lehrer, S. Isenberg, and S. M. Hochron, “Asthma and emotion: a review,” Journal of Asthma, vol. 30, no. 1, pp. 5–21, 1993. View at Scopus
  29. M. A. Rosenkranz, W. W. Busse, T. Johnstone et al., “Neural circuitry underlying the interaction between emotion and asthma symptom exacerbation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 37, pp. 13319–13324, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. M. Teufel, T. Biedermann, N. Rapps et al., “Psychological burden of food allergy,” World Journal of Gastroenterology, vol. 13, no. 25, pp. 3456–3465, 2007. View at Scopus
  31. D. C. Cara, A. A. Conde, and N. M. Vaz, “Immunological induction of flavor aversion in mice,” Brazilian Journal of Medical and Biological Research, vol. 27, no. 6, pp. 1331–1341, 1994. View at Scopus
  32. D. C. Cara, A. A. Conde, and N. M. Vaz, “Immunological induction of flavour aversion in mice. II. Passive/adoptive transfer and pharmacological inhibition,” Scandinavian Journal of Immunology, vol. 45, no. 1, pp. 16–20, 1997. View at Scopus
  33. G. Teixeira, “Selection of diets by mice immunized to peanuts and cashew nut proteins,” in Dept of Immunology and Biochemistry, UFMG, Federal University of MInas Gerais, Belo Horizonte, Brazil, 1995.
  34. F. Bermúdez-Rattoni, “Molecular mechanisms of taste-recognition memory,” Nature Reviews Neuroscience, vol. 5, no. 3, pp. 209–217, 2004. View at Scopus
  35. A. S. Basso, F. A. Costa Pinto, M. Russo, L. R. Giorgetti Britto, L. C. de Sá-Rocha, and J. Palermo Neto, “Neural correlates of IgE-mediated food allergy,” Journal of Neuroimmunology, vol. 140, no. 1-2, pp. 69–77, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. A. S. Basso, F. A. Costa-Pinto, L. R. Giorgetti Britto, L. C. De Sá-Rocha, and J. Palermo-Neto, “Neural pathways involved in food allergy signaling in the mouse brain: role of capsaicin-sensitive afferents,” Brain Research, vol. 1009, no. 1-2, pp. 181–188, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. N. Castex, J. Fioramonti, M. J. Fargeas, and L. Bueno, “c-fos expression in specific rat brain nuclei after intestinal anaphylaxis: involvement of 5-HT3 receptors and vagal afferent fibers,” Brain Research, vol. 688, no. 1-2, pp. 149–160, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. S. C. Heinrichs, F. Menzaghi, E. M. Pich, K. T. Britton, and G. F. Koob, “The role of CRF in behavioral aspects of stress,” Annals of the New York Academy of Sciences, vol. 771, pp. 92–104, 1995. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Arborelius, M. J. Owens, P. M. Plotsky, and C. B. Nemeroff, “The role of corticotropin-releasing factor in depression and anxiety disorders,” Journal of Endocrinology, vol. 160, no. 1, pp. 1–12, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. A. J. Mitchell, “The role of corticotropin releasing factor in depressive illness: a critical review,” Neuroscience and Biobehavioral Reviews, vol. 22, no. 5, pp. 635–651, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Holsboer and M. Ising, “Central CRH system in depression and anxiety—evidence from clinical studies with CRH receptor antagonists,” European Journal of Pharmacology, vol. 583, no. 2-3, pp. 350–357, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. D. H. Overstreet, A. Keeney, and S. Hogg, “Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression,” European Journal of Pharmacology, vol. 492, no. 2-3, pp. 195–201, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. D. M. Nielsen, G. J. Carey, and L. H. Gold, “Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice,” European Journal of Pharmacology, vol. 499, no. 1-2, pp. 135–146, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. T. Yamamoto, N. Sako, N. Sakai, and A. Iwafune, “Gustatory and visceral inputs to the amygdala of the rat: conditioned taste aversion and induction of c-fos-like immunoreactivity,” Neuroscience Letters, vol. 226, no. 2, pp. 127–130, 1997. View at Publisher · View at Google Scholar · View at Scopus
  45. J. W. Jahng, J. H. Lee, S. Lee et al., “Nω-nitro-L-arginine methyl ester attenuates lithium-induced c-Fos, but not conditioned taste aversion, in rats,” Neuroscience Research, vol. 50, no. 4, pp. 485–492, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. R. Lamprecht and Y. Dudai, “Differential modulation of brain immediate early genes by intraperitoneal LiCl,” NeuroReport, vol. 7, no. 1, pp. 289–293, 1995. View at Scopus
  47. F. A. Costa-Pinto, A. S. Basso, L. R. G. Britto, B. E. Malucelli, and M. Russo, “Avoidance behavior and neural correlates of allergen exposure in a murine model of asthma,” Brain, Behavior, and Immunity, vol. 19, no. 1, pp. 52–60, 2005. View at Publisher · View at Google Scholar · View at PubMed
  48. J. Kalesnikoff and S. J. Galli, “New developments in mast cell biology,” Nature Immunology, vol. 9, no. 11, pp. 1215–1223, 2008. View at Publisher · View at Google Scholar · View at PubMed
  49. E. C. Zarzana, A. S. Basso, F. A. Costa-Pinto, and J. Palermo-Neto, “Pharmacological manipulation of immune-induced food aversion in rats,” NeuroImmunoModulation, vol. 16, no. 1, pp. 19–27, 2009. View at Publisher · View at Google Scholar · View at PubMed
  50. K. de Bosscher and G. Haegeman, “Minireview: latest perspectives on antiinflammatory actions of glucocorticoids,” Molecular Endocrinology, vol. 23, no. 3, pp. 281–291, 2009. View at Publisher · View at Google Scholar · View at PubMed
  51. F. A. Stuart, T. Y. Segal, and S. Keady, “Adverse psychological effects of corticosteroids in children and adolescents,” Archives of Disease in Childhood, vol. 90, no. 5, pp. 500–506, 2005. View at Publisher · View at Google Scholar · View at PubMed
  52. J. Bienenstock, J. Denburg, R. Scicchitano, R. Stead, M. Perdue, and A. Stanisz, “Role of neuropeptides, nerves and mast cells in intestinal immunity and physiology,” Monographs in Allergy, vol. 24, pp. 134–143, 1988.
  53. J. Bienenstock, M. Perdue, M. Blennerhassett et al., “Inflammatory cells and the epithelium. Mast cell/nerve interactions in the lung in vitro and in vivo,” American Review of Respiratory Disease, vol. 138, no. 6, pp. S31–S34, 1988.
  54. R. H. Stead, M. F. Dixon, N. H. Bramwell, R. H. Riddell, and J. Bienenstock, “Mast cells are closely apposed to nerves in the human gastrointestinal mucosa,” Gastroenterology, vol. 97, no. 3, pp. 575–585, 1989.
  55. R. M. Williams, H. R. Berthoud, and R. H. Stead, “Vagal afferent nerve fibres contact mast cells in rat small intestinal mucosa,” Neuroimmunomodulation, vol. 4, no. 5-6, pp. 266–270, 1998.
  56. R. Greene, J. Fowler, D. MacGlashan, and D. Weinreich, “IgE-challenged human lung mast cells excite vagal sensory neurons in vitro,” Journal of Applied Physiology, vol. 64, no. 5, pp. 2249–2253, 1988.
  57. J. A. Kiernan, “Degranulation of mast cells in the trachea and bronchi of the rat following stimulation of the vagus nerve,” International Archives of Allergy and Applied Immunology, vol. 91, no. 4, pp. 398–402, 1990.
  58. J. E. Blalock, “The immune system as the sixth sense,” Journal of Internal Medicine, vol. 257, no. 2, pp. 126–138, 2005. View at Publisher · View at Google Scholar · View at PubMed
  59. D. Grundy, “Neuroanatomy of visceral nociception: vagal and splanchnic afferent,” Gut, vol. 51, no. 1, pp. i2–i5, 2002.
  60. S. F. Maier, L. E. Goehler, M. Fleshner, and L. R. Watkins, “The role of the vagus nerve in cytokine-to-brain communication,” Annals of the New York Academy of Sciences, vol. 840, pp. 289–300, 1998. View at Publisher · View at Google Scholar
  61. P. Holzer, “Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons,” Pharmacological Reviews, vol. 43, no. 2, pp. 143–201, 1991.
  62. A. S. Basso, L. C. de Sá-Rocha, and J. Palermo-Neto, “Immune-induced flavor aversion in mice: modification by neonatal capsaicin treatment,” NeuroImmunoModulation, vol. 9, no. 2, pp. 88–94, 2001. View at Publisher · View at Google Scholar
  63. P. M. Lang, G. Moalem-Taylor, D. J. Tracey, H. Bostock, and P. Grafe, “Activity-dependent modulation of axonal excitability in unmyelinated peripheral rat nerve fibers by the 5-HT3 serotonin receptor,” Journal of Neurophysiology, vol. 96, no. 6, pp. 2963–2971, 2006. View at Publisher · View at Google Scholar · View at PubMed
  64. T. Andoh and Y. Kuraishi, “Expression of Fc epsilon receptor I on primary sensory neurons in mice,” NeuroReport, vol. 15, no. 13, pp. 2029–2031, 2004. View at Publisher · View at Google Scholar
  65. H. van der Kleij, N. Charles, K. Karimi et al., “Evidence for neuronal expression of functional Fc (ε{lunate} and γ) receptors,” Journal of Allergy and Clinical Immunology, vol. 125, no. 3, pp. 757–760, 2010. View at Publisher · View at Google Scholar · View at PubMed
  66. J. Garcia, P. S. Lasiter, F. Bermudez-Rattoni, and D. A. Deems, “A general theory of aversion learning,” Annals of the New York Academy of Sciences, vol. 443, pp. 8–21, 1985.
  67. L. Mirotti, D. Mucida, L. C. de Sá-Rocha, F. A. Costa-Pinto, and M. Russo, “Food aversion: a critical balance between allergen-specific IgE levels and taste preference,” Brain, Behavior, and Immunity, vol. 24, no. 3, pp. 370–375, 2010. View at Publisher · View at Google Scholar · View at PubMed
  68. F. A. Costa-Pinto, A. S. Basso, and M. Russo, “Role of mast cell degranulation in the neural correlates of the immediate allergic reaction in a murine model of asthma,” Brain, Behavior, and Immunity, vol. 21, no. 6, pp. 783–790, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. F. Lechin, B. van der Dijs, B. Orozco et al., “Neuropharmacologic treatment of bronchial asthma with the antidepressant tianeptine: a double-blind, crossover placebo-controlled study,” Clinical Pharmacology and Therapeutics, vol. 64, no. 2, pp. 223–232, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. H. Bayer, T. Müller, D. Myrtek et al., “Serotoninergic receptors on human airway epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 36, no. 1, pp. 85–93, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. E. J. Essman, “Serotonin receptors on pulmonary alveolar macrophages,” La Ricerca in Clinica e in Laboratorio, vol. 15, no. 1, pp. 19–24, 1985. View at Publisher · View at Google Scholar · View at Scopus
  72. L. A. Weigand, A. C. Myers, S. Meeker, and B. J. Undem, “Mast cell-cholinergic nerve interaction in mouse airways,” Journal of Physiology, vol. 587, no. 13, pp. 3355–3362, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. L. D. Bellinger, C. Lubahn, and L. D. Felten, Innervation of Lymphoid Organs Association of Nerves with Cells of The Immune System and Their Implications in Diseasein Psychoneuroimmunology, chapter 2, Academic Press, New York, NY, USA, 3rd edition, 2001.
  74. I. J. Elenkov, G. Haskó, K. J. Kovács, and E. S. Vizi, “Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α- and β-adrenergic drugs in mice,” Journal of Neuroimmunology, vol. 61, no. 2, pp. 123–131, 1995. View at Publisher · View at Google Scholar · View at Scopus
  75. G. Haskó and C. Szabó, “Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system,” Biochemical Pharmacology, vol. 56, no. 9, pp. 1079–1087, 1998. View at Publisher · View at Google Scholar · View at Scopus
  76. R. H. Straub, R. Wiest, U. G. Strauch, P. Härle, and J. Schölmerich, “The role of the sympathetic nervous system in intestinal inflammation,” Gut, vol. 55, no. 11, pp. 1640–1649, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. D. L. Bellinger, B. A. Millar, S. Perez et al., “Sympathetic modulation of immunity: relevance to disease,” Cellular Immunology, vol. 252, no. 1-2, pp. 27–56, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. K. S. Madden, “Catecholamines, sympathetic innervation, and immunity,” Brain, Behavior, and Immunity, vol. 17, no. 1, pp. S5–S10, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. V. M. Sanders, R. A. Baker, D. S. Ramer-Quinn, D. J. Kasprowicz, B. A. Fuchs, and N. E. Street, “Differential expression of the β-adrenergic receptor by Th1 and Th2 clones implications for cytokine production and B cell help,” Journal of Immunology, vol. 158, no. 9, pp. 4200–4210, 1997. View at Scopus
  80. V. M. Sanders and A. E. Munson, “Beta adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro,” Journal of Pharmacology and Experimental Therapeutics, vol. 230, no. 1, pp. 183–192, 1984. View at Scopus
  81. D. S. Ramer-Quinn, R. A. Baker, and V. M. Sanders, “Activated T helper 1 and T helper 2 cells differentially express the β-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production,” Journal of Immunology, vol. 159, no. 10, pp. 4857–4867, 1997. View at Scopus
  82. C. A. Cazaux, L. Sterin-Borda, G. Gorelik, and G. A. Cremaschi, “Down-regulation of β-adrenergic receptors induced by mitogen activation of intracellular signaling events in lymphocytes,” FEBS Letters, vol. 364, no. 2, pp. 120–124, 1995. View at Publisher · View at Google Scholar · View at Scopus
  83. A. De Blasi, G. Parruti, and M. Sallese, “Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes. Selective increase of β-adrenergic receptor kinase 1 and 2,” Journal of Clinical Investigation, vol. 95, no. 1, pp. 203–210, 1995. View at Scopus
  84. T. Diamantstein and A. Ulmer, “The antagonistic action of cyclic GMP and cyclic AMP on proliferation of B and T lymphocytes,” Immunology, vol. 28, no. 1, pp. 113–119, 1975. View at Scopus
  85. T. Takamoto, Y. Hori, Y. Koga, H. Toshima, A. Hara, and M. M. Yokoyama, “Norepinephrine inhibits human natural killer cell activity in vitro,” International Journal of Neuroscience, vol. 58, no. 1-2, pp. 127–131, 1991. View at Scopus
  86. R. N. Spengler, R. M. Allen, D. G. Remick, R. M. Strieter, and S. L. Kunkel, “Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor,” Journal of Immunology, vol. 145, no. 5, pp. 1430–1434, 1990. View at Scopus
  87. A. del Rey, H. O. Besedovsky, E. Sorkin, M. Da Prada, and G. P. Bondiolotti, “Sympathetic immunoregulation: difference between high- and low-responder animals,” American Journal of Physiology, vol. 242, no. 1, pp. R30–R33, 1982. View at Scopus
  88. A. P. Kohm, Y. Tang, V. M. Sanders, and S. B. Jones, “Activation of antigen-specific CD4+ Th2 cells and B cells in vivo increases norepinephrine release in the spleen and bone marrow,” Journal of Immunology, vol. 165, no. 2, pp. 725–733, 2000. View at Scopus
  89. B. A. Fuchs, K. S. Campbell, and A. E. Munson, “Norepinephrine and serotonin content of the mureine spleen: its relationship to lymphocyte β-adrenergic receptor density and the humoral immune response in vivo and in vitro,” Cellular Immunology, vol. 117, no. 2, pp. 339–351, 1988. View at Scopus
  90. B. J. MacNeil, A. H. Jansen, L. J. Janz, A. H. Greenberg, and D. M. Nance, “Peripheral endotoxin increases splenic sympathetic nerve activity via central prostaglandin synthesis,” American Journal of Physiology, vol. 273, no. 2, pp. R609–R614, 1997. View at Scopus
  91. D. L. Felten, S. Livnat, and S. Y. Felten, “Sympathetic innervation of lymph nodes in mice,” Brain Research Bulletin, vol. 13, no. 6, pp. 693–699, 1984. View at Publisher · View at Google Scholar · View at Scopus
  92. V. E. Sergeeva, “Histotopography of catecholamines in the mammalian thymus,” Bulletin of Experimental Biology and Medicine, vol. 77, no. 4, pp. 456–458, 1974. View at Scopus
  93. G. Kudoh, K. Hoshi, and T. Murakami, “Fluorescence microscopic and enzyme histochemical studies of the innervation of the human spleen,” Archivum Histologicum Japonicum, vol. 42, no. 2, pp. 169–180, 1979. View at Scopus
  94. H. O. Besedovsky, A. Del Rey, E. Sorkin et al., “T lymphocytes affect the development of sympathetic innervation of mouse spleen,” Brain Behavior and Immunity, vol. 1, no. 2, pp. 185–193, 1987. View at Scopus
  95. D. M. Nance and V. M. Sanders, “Autonomic innervation and regulation of the immune system (1987–2007),” Brain, Behavior, and Immunity, vol. 21, no. 6, pp. 736–745, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. A. J. Shepherd, J. E. G. Downing, and J. A. Miyan, “Without nerves, immunology remains incomplete—in vivo veritas,” Immunology, vol. 116, no. 2, pp. 145–163, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  97. D. J. van Westerloo, I. A. Giebelen, S. Florquin et al., “The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice,” Gastroenterology, vol. 130, no. 6, pp. 1822–1830, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. J. E. Ghia, P. Blennerhassett, H. Kumar-Ondiveeran, E. F. Verdu, and S. M. Collins, “The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model,” Gastroenterology, vol. 131, no. 4, pp. 1122–1130, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. F. O. The, G. E. Boeckxstaens, S. A. Snoek et al., “Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice,” Gastroenterology, vol. 133, no. 4, pp. 1219–1228, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  100. L. V. Borovikova, S. Ivanova, M. Zhang et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, no. 6785, pp. 458–462, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  101. B. Cai, F. Chen, Y. Ji et al., “Alpha7 cholinergic-agonist prevents systemic inflammation and improves survival during resuscitation,” Journal of Cellular and Molecular Medicine, vol. 13, no. 9B, pp. 3774–3785, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  102. I. K. Wessler and C. J. Kirkpatrick, “The non-neuronal cholinergic system: an emerging drug target in the airways,” Pulmonary Pharmacology and Therapeutics, vol. 14, no. 6, pp. 423–434, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  103. K. Racké and S. Matthiesen, “The airway cholinergic system: physiology and pharmacology,” Pulmonary Pharmacology and Therapeutics, vol. 17, no. 4, pp. 181–198, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  104. C. Woiciechowsky, K. Asadullah, D. Nestler et al., “Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury,” Nature Medicine, vol. 4, no. 7, pp. 808–813, 1998. View at Publisher · View at Google Scholar · View at Scopus
  105. L. E. Miller, J. Grifka, J. Schölmerich, and R. H. Straub, “Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis,” Journal of Rheumatology, vol. 29, no. 3, pp. 427–435, 2002. View at Scopus
  106. K. J. Tracey, “The inflammatory reflex,” Nature, vol. 420, no. 6917, pp. 853–859, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  107. J. K. Voice, C. Grinninger, Y. Kong, Y. Bangale, S. Paul, and E. J. Goetzl, “Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice,” Journal of Immunology, vol. 170, no. 1, pp. 308–314, 2003. View at Scopus
  108. M. C. Grimm, R. Newman, Z. Hassim et al., “Cutting edge: vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors,” Journal of Immunology, vol. 171, no. 10, pp. 4990–4994, 2003. View at Scopus
  109. C. Martinez, C. Abad, M. Delgado et al., “Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 2, pp. 1053–1058, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  110. S. D. Brain and T. J. Williams, “Substance P regulates the vasodilator activity of calcitonin gene-related peptide,” Nature, vol. 335, no. 6185, pp. 73–75, 1988. View at Scopus
  111. M. Steinhoff, N. Vergnolle, S. H. Young et al., “Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism,” Nature Medicine, vol. 6, no. 2, pp. 151–158, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  112. R. Pedotti, D. Mitchell, J. Wedemeyer et al., “An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide,” Nature Immunology, vol. 2, no. 3, pp. 216–222, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  113. M. Jutel, T. Watanabe, S. Klunker et al., “Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors,” Nature, vol. 413, no. 6854, pp. 420–425, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  114. S. Poliak, F. Mor, P. Conlon et al., “Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system,” Journal of Immunology, vol. 158, no. 12, pp. 5751–5756, 1997. View at Scopus
  115. L. Steinman, P. Conlon, R. Maki, and A. Foster, “The intricate interplay among body weight, stress, and the immune response to friend or foe,” Journal of Clinical Investigation, vol. 111, no. 2, pp. 183–185, 2003. View at Publisher · View at Google Scholar · View at Scopus
  116. S. Grabbe, R. S. Bhardwaj, K. Mahnke, M. M. Simon, T. Schwarz, and T. A. Luger, “α-melanocyte-stimulating hormone induces hapten-specific tolerance in mice,” Journal of Immunology, vol. 156, no. 2, pp. 473–478, 1996. View at Scopus
  117. J. W. Streilein, S. Okamoto, Y. Sano, and A. W. Taylor, “Neural control of ocular immune privilege,” Annals of the New York Academy of Sciences, vol. 917, pp. 297–306, 2000. View at Scopus
  118. C. Fekete and Z. Liposits, “Histamine-immunoreactive neurons of the tuberomammillary nucleus are innervated by α-melanocyte stimulating hormone-containing axons. Generation of a new histamine antiserum for ultrastructural studies,” Brain Research, vol. 969, no. 1-2, pp. 70–77, 2003. View at Publisher · View at Google Scholar
  119. G. Matarese, A. Di Giacomo, V. Sanna et al., “Requirement for leptin in the induction and progression of autoimmune encephalomyelitis,” Journal of Immunology, vol. 166, no. 10, pp. 5909–5916, 2001. View at Scopus
  120. V. Sanna, A. Di Giacomo, A. La Cava et al., “Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses,” Journal of Clinical Investigation, vol. 111, no. 2, pp. 241–250, 2003. View at Publisher · View at Google Scholar · View at Scopus
  121. H. Baumann, K. K. Morella, D. W. White et al., “The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 16, pp. 8374–8378, 1996. View at Publisher · View at Google Scholar · View at Scopus
  122. G. E. Demas, “Splenic denervation blocks leptin-induced enhancement of humoral immunity in Siberian hamsters (Phodopus sungorus),” Neuroendocrinology, vol. 76, no. 3, pp. 178–184, 2002. View at Publisher · View at Google Scholar · View at Scopus
  123. D. V. Rayner and P. Trayhurn, “Regulation of leptin production: sympathetic nervous system interactions,” Journal of Molecular Medicine, vol. 79, no. 1, pp. 8–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  124. EL. B. Haddad, J. C. W. Mak, M. G. Belvisi, M. Nishikawa, J. Rousell, and P. J. Barnes, “Muscarinic and β-adrenergic receptor expression in peripheral lung from normal and asthmatic patients,” American Journal of Physiology, vol. 270, no. 6, pp. L947–L953, 1996. View at Scopus
  125. J. I. Galzi and J. P. Changeux, “Neuronal nicotinic receptors: molecular organization and regulations,” Neuropharmacology, vol. 34, no. 6, pp. 563–582, 1995. View at Publisher · View at Google Scholar · View at Scopus
  126. B. M. Conti-Tronconi, K. E. McLane, M. A. Raftery, S. A. Grando, and M. P. Protti, “The nicotinic acetylcholine receptor: structure and autoimmune pathology,” Critical Reviews in Biochemistry and Molecular Biology, vol. 29, no. 2, pp. 69–123, 1994. View at Scopus
  127. R. J. Lukas, J. P. Changeux, N. Le Novère et al., “International union of pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits,” Pharmacological Reviews, vol. 51, no. 2, pp. 397–401, 1999. View at Scopus
  128. F. Sgard, E. Charpantier, S. Bertrand et al., “A novel human nicotinic receptor subunit, α10, that confers functionality to the α9-subunit,” Molecular Pharmacology, vol. 61, no. 1, pp. 150–159, 2002. View at Publisher · View at Google Scholar
  129. R. M. Eglen, S. S. Hegde, and N. Watson, “Muscarinic receptor subtypes and smooth muscle function,” Pharmacological Reviews, vol. 48, no. 4, pp. 531–565, 1996. View at Scopus
  130. D. J. Adamko, B. L. Yost, G. J. Gleich, A. D. Fryer, and D. B. Jacoby, “Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection: eosinophils mediate airway hyperresponsiveness, M2 muscarinic receptor dysfunction, and antiviral effects,” Journal of Experimental Medicine, vol. 190, no. 10, pp. 1465–1477, 1999. View at Publisher · View at Google Scholar · View at Scopus
  131. A. H. Schultheis, D. J. P. Bassett, and A. D. Fryer, “Ozone-induced airway hyperresponsiveness and loss of neuronal M2 muscarinic receptor function,” Journal of Applied Physiology, vol. 76, no. 3, pp. 1088–1097, 1994. View at Scopus
  132. G. L. Larsen, T. M. Fame, H. Renz et al., “Increased acetylcholine release in tracheas from allergen-exposed IgE- immune mice,” American Journal of Physiology, vol. 266, no. 3, part 1, pp. L263–L270, 1994. View at Scopus
  133. A. D. Fryer and M. Wills-Karp, “Dysfunction of M2-muscarinic receptors in pulmonary parasympathetic nerves after antigen challenge,” Journal of Applied Physiology, vol. 71, no. 6, pp. 2255–2261, 1991. View at Scopus
  134. P. A. H. Minette, J. W. J. Lammers, C. M. S. Dixon, M. T. McCusker, and P. J. Barnes, “A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects,” Journal of Applied Physiology, vol. 67, no. 6, pp. 2461–2465, 1989. View at Scopus
  135. L. E. Ayala and T. Ahmed, “Is there loss of a protective muscarinic receptor mechanism in asthma?” Chest, vol. 96, no. 6, pp. 1285–1291, 1989. View at Scopus
  136. D. B. Jacoby, G. J. Gleich, and A. D. Fryer, “Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor,” Journal of Clinical Investigation, vol. 91, no. 4, pp. 1314–1318, 1993. View at Scopus
  137. D. F. Rogers, “Motor control of airway goblet cells and glands,” Respiration Physiology, vol. 125, no. 1-2, pp. 129–144, 2001. View at Publisher · View at Google Scholar · View at Scopus
  138. M. Rosas-Ballina and K. J. Tracey, “Cholinergic control of inflammation,” Journal of Internal Medicine, vol. 265, no. 6, pp. 663–679, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  139. D. J. van Westerloo, “The vagal immune reflex: a blessing from above,” Wiener Medizinische Wochenschrift, vol. 160, no. 5-6, pp. 112–117, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  140. K. Matsunaga, T. W. Klein, H. Friedman, and Y. Yamamoto, “Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine,” Journal of Immunology, vol. 167, no. 11, pp. 6518–6524, 2001. View at Scopus
  141. A. Orr-Urtreger, M. Kedmi, S. Rosner, F. Karmeli, and D. Rachmilewitz, “Increased severity of experimental colitis in alpha 5 nicotinic acetylcholine receptor subunit-deficient mice,” NeuroReport, vol. 16, no. 10, pp. 1123–1127, 2005. View at Publisher · View at Google Scholar · View at Scopus
  142. K. Karimi, J. Bienenstock, LU. Wang, and P. Forsythe, “The vagus nerve modulates CD4+ T cell activity,” Brain, Behavior, and Immunity, vol. 24, no. 2, pp. 316–323, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  143. M. R. Blanchet, E. Israël-Assayag, and Y. Cormier, “Modulation of airway inflammation and resistance in mice by a nicotinic receptor agonist,” European Respiratory Journal, vol. 26, no. 1, pp. 21–27, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  144. M. R. Blanchet, A. Langlois, E. Israël-Assayag et al., “Modulation of eosinophil activation in vitro by a nicotinic receptor agonist,” Journal of Leukocyte Biology, vol. 81, no. 5, pp. 1245–1251, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus